Lime Therapeutics
New York, US · Founded 2021 · 6 employees on LinkedIn · 3 known investors
Find your way into Lime Therapeutics
Sign up to see every warm intro you have to Lime Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lime Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders. The company uses LipidSense, a proprietary ultrasensitive lipid detection platform, to discover and develop therapeutics targeting lipid dysfunction.
Founders & leadership
Lime Therapeutics was founded in 2021 by Prakrit V. Jena.

Investors · 3
How we know: Epakon Capital's portfolio page · Not right? Tell us
How we know: HBS Angels of Boston's portfolio page · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Lime Therapeutics do?
- Lime Therapeutics is a biotechnology company developing lipid-altering medicines for cancer, cardiometabolic diseases, lysosomal storage diseases, and neurodegenerative disorders. The company uses LipidSense, a proprietary ultrasensitive lipid detection platform, to discover and develop therapeutics targeting lipid dysfunction.
- Who founded Lime Therapeutics?
- Lime Therapeutics was founded by Prakrit V. Jena in 2021.
- Who are Lime Therapeutics's investors?
- Lime Therapeutics's investors include Epakon Capital, HBS Angels of Boston, ZAKA VC.
- Where is Lime Therapeutics headquartered?
- Lime Therapeutics is headquartered in New York, US.


